标普和纳斯达克内在价值 联系我们

Cellectis S.A. CMVLF OTC

Other OTC • Healthcare • Biotechnology • FR • USD

SharesGrow Score
35/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cellectis S.A. (CMVLF) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 34/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
35/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
75/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
33/100
Debt-to-Equity & liquidity
→ Health
护城河
35/100
→ Income
~
成长
58/100
→ Income
收入
10/100
→ Income

估值概览 — CMVLF

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率4.07
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.70
每股账面价值$0.00
每股营收$0.76
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-1.78 $42.58M $-63.92M -150.1%
2017 $-2.78 $25.19M $-99.37M -394.5%
2018 $-1.93 $12.73M $-78.69M -618.1%
2019 $-2.41 $15.19M $-102.09M -672.1%
2020 $-1.91 $73.95M $-81.07M -109.6%
2021 $-1.81 $73.95M $-81.07M -109.6%
2022 $-2.33 $19.17M $-106.14M -553.6%
2023 $-1.77 $755K $-103.17M -13665.4%
2024 $-0.41 $41.51M $-36.76M -88.6%
2025 $-0.70 $75.92M $-70.34M -92.7%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言